Evidence map›Paper›PMID 32552113›Full record

ReviewThe Journal of international medical research2020

Brucellar reproductive system injury: A retrospective study of 22 cases and review of the literature.

Yan Zhou, Songsong Xie, Rongjiong Zheng, Qinqi Dai, Zheng Xu, Weize Zuo, Jianbing Ding, Yuexin Zhang

Open access · goldAbstract readReview
In one paragraph

Review in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Research progress on complications ofFrontiers in cellular and infection microbiology · 2023
    Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yan ZhouDepartment of Infection Disease Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.ORCID https://orcid.org/0000-0002-8908-7688
Songsong XieThe First Hospital of Shihezi University, Shihezi, Xinjiang, China.ORCID https://orcid.org/0000-0003-0307-6425
Rongjiong ZhengDepartment of Infection Disease Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Qinqi DaiDepartment of Infection Disease Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Zheng XuDepartment of Infection Disease Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Weize ZuoThe First Hospital of Shihezi University, Shihezi, Xinjiang, China.
Jianbing DingDepartment of Immunology, Basic Medical College, Xinjiang Medical University, Urumqi, China.
Yuexin ZhangDepartment of Infection Disease Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Xinjiang Medical University · CNShihezi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe aimed to describe the clinical characteristics and prognosis of 22 patients with

methodsWe assessed 22 patients with reproductive system injury between 2010 and 2018 at The First Affiliated Hospital of Xinjiang Medical University.

resultsThe disease is predominant in men. Male patients had orchitis, erectile dysfunction, prostatitis, and urethral stricture, while female patients had vaginitis and cervicitis. Some patients had laboratory abnormalities and liver injury. Patients received combination therapy of rifampicin and doxycycline. Doxycycline combined with levofloxacin or moxifloxacin was administered to patients with rifampicin intolerance. All patients had received antibiotic therapy for at least 6 weeks. One patient was lost to follow-up, one patient relapsed because of osteoarthropathy, and one patient had dysuria resulting from chronic prostatitis. The clinical symptoms resolved in the other patients, and the overall patient prognosis was good.

conclusionClinicians should pay attention to brucellosis-induced reproductive system damage. The two-drug regimen of rifampicin+doxycycline is recommended for these patients. Doxycycline combined with levofloxacin or moxifloxacin should be used in patients with brucellosis-induced reproductive system damage who have rifampicin intolerance. The treatment course should be at least 6 weeks.

Indexed as

AdultAgedAged, 80 and overAnti-Bacterial AgentsBrucellaBrucellosisChinaDoxycyclineDrug Therapy, CombinationFemaleGenitaliaHumansLevofloxacinMaleMiddle AgedMoxifloxacinAnti-Bacterial AgentsDoxycyclineLevofloxacinMoxifloxacinRifampinBrucellosisclinical featuresdoxycyclinelevofloxacinmoxifloxacinreproductive systemrifampicin intolerance

Identifiers

PMID32552113
PMCPMC7303501
OpenAlexW3036810364

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.